1.1
Peginterferon alfa-2a is recommended as an option for the initial treatment of adults with chronic hepatitis B (HBeAg-positive or HBeAg-negative), within its licensed indications.
1 Recommendations
This guidance does not apply to people with chronic hepatitis B known to be co‑infected with hepatitis C, hepatitis D or HIV.
1.2
This recommendation has been replaced by recommendation 1.5.13 in NICE's guideline on hepatitis B (chronic): diagnosis and management.
1.3
This recommendation has been replaced by recommendation 1.5.14 in NICE's guideline on hepatitis B (chronic): diagnosis and management.
1.4
This recommendation has been replaced by recommendation 1.5.15 in NICE's guideline on hepatitis B (chronic): diagnosis and management.